NDC 59762-2420-07 - Doxazosin mesylate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 59762-2420
- Requested NDC
- 59762-2420-07
- Package NDCs from labels
- 59762-2420-7, 59762-2420-07
- Manufacturer
- Mylan Pharmaceuticals Inc.
- Effective date
- 2022-01-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Doxazosin mesylate - Mylan Pharmaceuticals Inc. | Mylan Pharmaceuticals Inc. | 2022-01-20 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59762-2420-7 | Doxazosin | 100 in 1 BOTTLE | TABLET | 100 | 18 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 59762-2420 | DOXAZOSIN MESYLATE TABLET DOXAZOSIN TABLET [MYLAN PHARMACEUTICALS INC.] | 17 | Current NDC, Legacy NDC, 1 package rows | 20250511_6b887aa5-5edf-48c5-a480-dea8c35afa9d.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 59762-2420-7 | EA - Each | 59762-2420 | eeb9b45d-259e-41ba-bb1a-eb31636b753f | 1 | 2021-11-09 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| DOXAZOSIN MESYLATE | ACTIVE INGREDIENT | 86P6PQK0MU | DOXAZOSIN MESYLATE TABLET [GREENSTONE LLC] | 2 | |
| DOXAZOSIN | ACTIVE MOIETY | NW1291F1W8 | DOXAZOSIN MESYLATE TABLET [GREENSTONE LLC] | 2 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | DOXAZOSIN MESYLATE TABLET [GREENSTONE LLC] | 2 | |
| D&C YELLOW NO. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | DOXAZOSIN MESYLATE TABLET [GREENSTONE LLC] | 2 | |
| FD&C YELLOW NO. 6 | INACTIVE INGREDIENT | H77VEI93A8 | DOXAZOSIN MESYLATE TABLET [GREENSTONE LLC] | 2 | |
| LACTOSE | INACTIVE INGREDIENT | J2B2A4N98G | DOXAZOSIN MESYLATE TABLET [GREENSTONE LLC] | 2 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | DOXAZOSIN MESYLATE TABLET [GREENSTONE LLC] | 2 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | DOXAZOSIN MESYLATE TABLET [GREENSTONE LLC] | 2 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | DOXAZOSIN MESYLATE TABLET [GREENSTONE LLC] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Doxazosin | DOXAZOSIN | REMEDYREPACK INC. | 30a6bb83-f91b-4c4f-a849-4f2be3735a0e | 2026-08-14 | Warnings, Adverse reactions | 197626 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Major Pharmaceuticals | 3354196f-bbcf-4bc5-94f6-e6e8e132acb1 | 2026-08-05 | Warnings, Adverse reactions | 197625 197626 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | REMEDYREPACK INC. | 71815e8f-33ed-4f36-a8ec-d4443151a9d8 | 2026-07-08 | Warnings, Adverse reactions | 197626 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Golden State Medical Supply, Inc. | 54eeef3d-c906-37e7-e063-6294a90afca2 | 2026-06-23 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | REMEDYREPACK INC. | bf2f7b41-f14d-4fcd-8db3-f507ca6ff78b | 2026-06-12 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | REMEDYREPACK INC. | ec06f008-37a1-4757-a3ee-0b4720912bc4 | 2026-06-11 | Warnings, Adverse reactions | 197626 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | PD-Rx Pharmaceuticals, Inc. | 2ea9bb6b-a4f0-496a-b27b-4454167a4b70 | 2026-05-13 | Warnings, Adverse reactions | 197626 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Cardinal Health 107, LLC | 08521333-ff21-45ad-b99e-1f43d945d24d | 2026-04-24 | Warnings, Adverse reactions | 197626 86P6PQK0MU |
| Doxazosin | DOXAZOSIN MESYLATE | Bryant Ranch Prepack | 277c3278-4fe2-47ac-9115-15b417325ffd | 2026-04-13 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Preferred Pharmaceuticals Inc. | 2110eec5-949d-4718-ad6d-3629e5db8a07 | 2026-04-08 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Preferred Pharmaceuticals Inc. | e046e0b7-f510-4318-9884-034d683864d4 | 2026-04-08 | Warnings, Adverse reactions | 197626 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | AvPAK | de9ab9a4-d8b8-8b36-e053-2a95a90aaa35 | 2026-03-24 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | AvKARE | e3d381c1-3b2f-af70-f4e6-08d6202eed25 | 2026-03-24 | Warnings, Adverse reactions | 197628 197626 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN MESYLATE | Bryant Ranch Prepack | e2f5d7d2-21aa-4921-8035-da945d3c565c | 2026-03-04 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | NuCare Pharmaceuticals, Inc. | 54116886-ea5e-5320-e054-00144ff8d46c | 2026-02-16 | Warnings, Adverse reactions | 197626 86P6PQK0MU |
| Doxazosin | DOXAZOSIN MESYLATE | Bryant Ranch Prepack | 8641cdb1-dc16-4a13-8a84-bc8f6d58b4d4 | 2026-02-13 | Warnings, Adverse reactions | 197626 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Bryant Ranch Prepack | 54549d19-6311-4dbb-8622-fd3e5440551a | 2026-01-29 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Northwind Health Company, LLC | f2b35586-d550-3fcb-e053-2995a90a3403 | 2026-01-19 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN MESYLATE | Northwind Health Company, LLC | f6c9856e-9154-f349-e053-6294a90a9f2c | 2026-01-19 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Northwind Health Company, LLC | f306adae-a2fe-5477-e053-2995a90a7838 | 2026-01-01 | Warnings, Adverse reactions | 197625 86P6PQK0MU |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.